Strategic MOU to Advance AI-Powered Cardiac Imaging

📍 Overview
Phantomics Inc., a deep-tech startup in medical imaging AI, has signed an MOU with Severance Cardiovascular Hospital, Korea’s top-tier heart care center. This partnership aims to accelerate clinical adoption and global validation of Phantomics’ flagship solutions:

• Myomics®: AI-powered cardiac MRI analysis 

• Angiomics®: AI solution for coronary CT analysis 

🔍 Key Objectives

• Co-develop AI algorithms using real-world hospital data

• Improve early diagnosis of heart failure, myocarditis, amyloidosis & more

• Validate and expand clinical applications across Asia and beyond

• Hold joint academic forums and publish collaborative research

💡 Why It Matters

• Faster diagnosis, better accuracy: 95%+ precision with AI-driven insights

• Global traction: Deployed in 20+ Korean hospitals and expanding across Japan, Taiwan, Singapore, Thailand, Europe — and soon, North America

• Proven innovation: CES Innovation Award & FIX Best Innovation Winner

• Severance strength: World-class hospital ranked by Newsweek, with 30,000+ ablation procedures and deep clinical expertise

🗣️ Leadership Quotes

“This partnership will strengthen the clinical value of AI in cardiac care and help save lives.”
– Panki Kim, Co-CEO, Phantomics
“We’re excited to combine our clinical depth with Phantomics' technology to improve early detection and outcomes.”
– Dr. Seok Min Kang, Director, Severance Cardiovascular Hospital

Related the Article :  Phantomics, Severance Hospital Partner to Combat Cardiovascular Disease with AI